These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 20048692
1. First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation. Di Benedetto F, Di Sandro S, De Ruvo N, Montalti R, Ballarin R, Guerrini GP, Spaggiari M, Guaraldi G, Gerunda G. Transplantation; 2010 Mar 27; 89(6):733-8. PubMed ID: 20048692 [Abstract] [Full Text] [Related]
2. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators. Liver Transpl; 2009 Sep 27; 15(9):1133-41. PubMed ID: 19718643 [Abstract] [Full Text] [Related]
3. University of Modena experience in HIV-positive patients undergoing liver transplantation. Di Benedetto F, Tarantino G, De Ruvo N, Cautero N, Montalti R, Guerrini GP, Ballarin R, Spaggiari M, Smerieri N, Serra V, Rompianesi G, D'Amico G, Mimmo A, Iemmolo RM, Codeluppi M, Cocchi S, Guaraldi G, Gerunda GE. Transplant Proc; 2011 May 27; 43(4):1114-8. PubMed ID: 21620066 [Abstract] [Full Text] [Related]
9. Liver transplantation in HIV/hepatitis co-infection. Miro JM, Aguero F, Laguno M, Tuset M, Cervera C, Moreno A, Garcia-Valdecasas JC, Rimola A, Hospital Clinic OLT in HIV Working Group. J HIV Ther; 2007 Mar 27; 12(1):24-35. PubMed ID: 17589393 [Abstract] [Full Text] [Related]
10. Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients. Duclos-Vallée JC, Vittecoq D, Teicher E, Feray C, Roque-Afonso AM, Lombès A, Jardel C, Gigou M, Dussaix E, Sebagh M, Guettier C, Azoulay D, Adam R, Ichaï P, Saliba F, Roche B, Castaing D, Bismuth H, Samuel D. J Hepatol; 2005 Mar 27; 42(3):341-9. PubMed ID: 15710216 [Abstract] [Full Text] [Related]
11. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J, EuroSIDA Study Group. J Infect Dis; 2005 Sep 15; 192(6):992-1002. PubMed ID: 16107951 [Abstract] [Full Text] [Related]
12. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals. Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD, HepaI.Co.N.A. Study Group, Italian Cohort Naive for Antiretrovirals Study Group. Clin Infect Dis; 2005 Jun 15; 40(12):e101-9. PubMed ID: 15909251 [Abstract] [Full Text] [Related]
14. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity. Tateo M, Roque-Afonso AM, Antonini TM, Medja F, Lombes A, Jardel C, Teicher E, Sebagh M, Roche B, Castaing D, Samuel D, Duclos-Vallee JC. AIDS; 2009 Jun 01; 23(9):1069-76. PubMed ID: 19417577 [Abstract] [Full Text] [Related]
18. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, Burgart L, Wiesner R, Kremers W, Rosen C, Charlton MR. Hepatology; 2000 Nov 01; 32(5):1125-30. PubMed ID: 11050065 [Abstract] [Full Text] [Related]